JAG1 and breast carcinoma: Moreover, JAG1, a ligand for Notch receptor, was previously found to be upregulated in drug-resistant breast cancer cells, and this CSC-driven drug resistance in ER+ breast cancer was correlated to the interaction of JAG1 and NOTCH4 in association with the Notch signaling pathway [56].